Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

XVIVO Heart Perfusion System (XHPS) With Supplemented XVIVO Heart Solution (SXHS)

NCT: NCT05881278 · ACTIVE_NOT_RECRUITING

NCT IDNCT05881278
StatusACTIVE_NOT_RECRUITING
Start Date2023-10-10
Completion2029-11

Brief Summary

The purpose of this study is to evaluate if Non-Ischemic Heart Preservation (NIHP) of extended criteria donor hearts using the XVIVO Heart Preservation System (XHPS) is a safe and effective way to preserve and transport hearts for transplantation.

Frequently Asked Questions

What is XVIVO Heart Perfusion System (XHPS) With Supplemented XVIVO Heart Solution (SXHS)?

XVIVO Heart Perfusion System (XHPS) With Supplemented XVIVO Heart Solution (SXHS) is a clinical trial registered under NCT05881278. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05881278?

The current status of NCT05881278 (XVIVO Heart Perfusion System (XHPS) With Supplemented XVIVO Heart Solution (SXHS)) is: ACTIVE_NOT_RECRUITING.

When did XVIVO Heart Perfusion System (XHPS) With Supplemented XVIVO Heart Solution (SXHS) start?

XVIVO Heart Perfusion System (XHPS) With Supplemented XVIVO Heart Solution (SXHS) started on 2023-10-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑